Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 3001-3050 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07078136
Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis
N/ARecruiting
130 participants
Started: Jul 28, 2025 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT07047703
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
PHASE1/PHASE2Recruiting
141 participants
Started: Jul 28, 2025 · Completed: Sep 30, 2028
1 condition1 sponsor8 locations
NCT07106580
Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization
PHASE1/PHASE2Recruiting
48 participants
Started: Jul 28, 2025 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT07046923
A Study of LY4175408 in Participants With Advanced Cancer
PHASE1Recruiting
240 participants
Started: Jul 28, 2025 · Completed: Jul 31, 2030
5 conditions1 sponsor24 locations
NCT07073417
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
PHASE2Recruiting
160 participants
Started: Jul 28, 2025 · Completed: Aug 23, 2027
2 conditions1 sponsor1 location
NCT06816368
Combined Pulsed Field and Radiofrequency Energy for Ablation of Ventricular Tachycardia
NARecruiting
30 participants
Started: Jul 28, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor3 locations
NCT07207772
EIT-guided PEEP Titration Versus Standard Ventilation in Bariatric Surgery
NARecruiting
118 participants
Started: Jul 28, 2025 · Completed: Dec 31, 2027
5 conditions1 sponsor1 location
NCT06422871
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
N/ARecruiting
100 participants
Started: Jul 28, 2025 · Completed: Dec 28, 2028
2 conditions1 sponsor3 locations
NCT06129734
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
PHASE1/PHASE2Recruiting
20 participants
Started: Jul 28, 2025 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT07088913
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Rosuvastatin in Healthy Participants
PHASE1Recruiting
18 participants
Started: Jul 28, 2025 · Completed: Sep 29, 2025
1 condition2 sponsors1 location
NCT06348108
Talquetamab in Combination With Iberdomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
32 participants
Started: Jul 28, 2025 · Completed: Jul 31, 2029
3 conditions3 sponsors1 location
NCT06285188
Immunomonitoring of Mold Invasive Infections
N/ARecruiting
20 participants
Started: Jul 28, 2025 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT07098390
Effect of Progressive Muscle Relaxation on Fear of Falling, Pain, and Anxiety in Arthroplasty Patients
NARecruiting
44 participants
Started: Jul 28, 2025 · Completed: Mar 25, 2026
1 condition1 sponsor1 location
NCT07016295
Monitoring Arm Recovery After Stroke (MARS)
N/ARecruiting
30 participants
Started: Jul 28, 2025 · Completed: Apr 30, 2027
1 condition2 sponsors1 location
NCT07036406
Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)
PHASE2Recruiting
40 participants
Started: Jul 28, 2025 · Completed: Jul 31, 2027
10 conditions1 sponsor1 location
NCT07122869
Eligibility of Patients Referred to Emergency Departments by Their General Practitioners for Care in Walk-in Clinics: A Single-Center Study in Île-de-France
N/ARecruiting
80 participants
Started: Jul 28, 2025 · Completed: Aug 30, 2025
6 conditions1 sponsor1 location
NCT07089641
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
PHASE1Recruiting
10 participants
Started: Jul 28, 2025 · Completed: Jul 30, 2028
5 conditions1 sponsor1 location
NCT06911502
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma (GOLSEEK-4)
PHASE3Recruiting
400 participants
Started: Jul 28, 2025 · Completed: Jul 31, 2030
1 condition1 sponsor160 locations
NCT07005752
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).
PHASE4Recruiting
484 participants
Started: Jul 28, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor6 locations
NCT07071519
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
PHASE3Recruiting
120 participants
Started: Jul 28, 2025 · Completed: Jul 31, 2034
1 condition1 sponsor10 locations
NCT07080905
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
PHASE3Recruiting
18 participants
Started: Jul 28, 2025 · Completed: Oct 24, 2033
1 condition1 sponsor2 locations
NCT07000149
A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC
PHASE3Recruiting
1,116 participants
Started: Jul 28, 2025 · Completed: Jul 29, 2032
1 condition2 sponsors33 locations
NCT07148128
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
PHASE1/PHASE2Recruiting
110 participants
Started: Jul 28, 2025 · Completed: Jan 31, 2028
5 conditions2 sponsors3 locations
NCT07096011
Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants
N/ARecruiting
40 participants
Started: Jul 28, 2025 · Completed: May 31, 2027
6 conditions1 sponsor1 location
NCT07136935
A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients
NARecruiting
20 participants
Started: Jul 28, 2025 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT07036718
NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice
N/ARecruiting
100 participants
Started: Jul 28, 2025 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT07050368
A Study Assessing Brain Activity, Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers
PHASE1Recruiting
20 participants
Started: Jul 28, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT07039929
Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants
PHASE1Recruiting
48 participants
Started: Jul 28, 2025 · Completed: Jan 3, 2026
1 condition1 sponsor1 location
NCT07127887
Language Translation of Knowledge Mobilization Resources
NARecruiting
350 participants
Started: Jul 28, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06537154
NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment
PHASE2/PHASE3Recruiting
688 participants
Started: Jul 28, 2025 · Completed: Dec 31, 2030
1 condition3 sponsors1 location
NCT06886477
Sickle Cell, Pain and Mediterranean Diet
NARecruiting
30 participants
Started: Jul 28, 2025 · Completed: Dec 1, 2026
4 conditions1 sponsor1 location
NCT07113860
Reframing Expectations About Aging - Physical Activity and Inclusive Reappraisal
NARecruiting
342 participants
Started: Jul 28, 2025 · Completed: Oct 31, 2027
2 conditions10 sponsors1 location
NCT06909136
A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis
PHASE1/PHASE2Recruiting
49 participants
Started: Jul 28, 2025 · Completed: May 15, 2028
1 condition1 sponsor1 location
NCT07166770
Community-Led COVID-19 Testing Intervention to Address Mistrust
NARecruiting
56 participants
Started: Jul 27, 2025 · Completed: Feb 1, 2026
2 conditions1 sponsor1 location
NCT06838832
Novel Allogenic CD19-targeting CAR-γδT Cell Therapy (QH103E) in r/r NHL
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 27, 2025 · Completed: Mar 1, 2028
1 condition1 sponsor1 location
NCT07188337
Characteristics of Diabetic Foot Ulcer Patients
N/ARecruiting
200 participants
Started: Jul 27, 2025 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT07055165
Connect2Care: Prostate Cancer Education and Screenings for African American Men
NARecruiting
466 participants
Started: Jul 26, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT07096882
SDTM001 Injection as Adjuvant Therapy for NSCLC Patients After Radical Surgical Resection
PHASE1Recruiting
22 participants
Started: Jul 26, 2025 · Completed: Jun 26, 2029
1 condition1 sponsor1 location
NCT07218965
Fostering Agricultural Relationships and Meaning - Thriving on Kinship
NARecruiting
65 participants
Started: Jul 26, 2025 · Completed: Jul 31, 2026
3 conditions1 sponsor1 location
NCT07120724
Real-World Study on Chinese Medicine for Treating Chikungunya Fever
N/ARecruiting
600 participants
Started: Jul 26, 2025 · Completed: Dec 26, 2026
1 condition1 sponsor1 location
NCT06778135
Neocortical Microarchitecture of Executive Function
NARecruiting
15 participants
Started: Jul 25, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06984328
Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)
PHASE2Recruiting
90 participants
Started: Jul 25, 2025 · Completed: Jul 15, 2029
3 conditions1 sponsor2 locations
NCT07094204
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
PHASE1Recruiting
364 participants
Started: Jul 25, 2025 · Completed: Apr 30, 2029
4 conditions1 sponsor4 locations
NCT06858761
Health-economic Assessment of Robot-assisted Bariatric Surgery
NARecruiting
482 participants
Started: Jul 25, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor16 locations
NCT06386055
Air Pollution and Physical Activity Study
NARecruiting
24 participants
Started: Jul 25, 2025 · Completed: Nov 30, 2025
2 conditions1 sponsor1 location
NCT07047365
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
PHASE3Recruiting
416 participants
Started: Jul 25, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor66 locations
NCT07044310
5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
PHASE2Recruiting
38 participants
Started: Jul 25, 2025 · Completed: Jul 25, 2027
5 conditions1 sponsor1 location
NCT07062055
BRAVE Study: QL1706 + Bevacizumab + SBRT for BCLC-C HCC With PVTT or Oligometastases
PHASE2Recruiting
46 participants
Started: Jul 25, 2025 · Completed: Jul 25, 2029
6 conditions1 sponsor1 location
NCT06977568
A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip
PHASE2Recruiting
32 participants
Started: Jul 25, 2025 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT07087743
Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab
NARecruiting
30 participants
Started: Jul 25, 2025 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location